Pro-and anti-inflammatory cytokines in tuberculosis: A two-edged sword in TB pathogenesis

Seminars in Immunology

Volumn 26, Issue 6, 2014, Pages 543-551

  Etna, Marilena Paola ^a   Giacomini, Elena ^a   Severa, Martina ^a   Coccia, Eliana Marina ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cytokine network; Cytokines; Danger signal; Immunoregulation; Mtb infection

Indexed keywords

CYTOKINE;

HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; LYMPH NODE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUBERCULOSIS; DENDRITIC CELL; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; LUNG; LUNG ALVEOLUS CELL; LUNG TUBERCULOSIS; MACROPHAGE; MICROBIOLOGY; PATHOLOGY; T LYMPHOCYTE;

CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LUNG; LYMPH NODES; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; PNEUMOCYTES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY;

EID: 84920001803     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2014.09.011     Document Type: Review

References (109)

1. Reichman L., Hershfield E. Lung biology in health and disease Tuberculosis: a comprehensive international approach 2000, Dekker, New York.
2. O'Garra A., Redford P.S., McNab F.W., Bloom C.I., Wilkinson R.J., Berry M.P. The immune response in tuberculosis. Annu Rev Immunol 2013, 31:475-527.
3. Lee H.M., Yuk J.M., Shin D.M., Jo E.K. Dectin-1 is inducible and plays an essential role for mycobacteria-induced innate immune responses in airway epithelial cells. J Clin Immunol 2009, 29:795-805.
4. Sharma M., Sharma S., Roy S., Varma S., Bose M. Pulmonary epithelial cells are a source of interferon-gamma in response to Mycobacterium tuberculosis infection. Immunol Cell Biol 2007, 85:229-237.
5. Roy S., Sharma S., Sharma M., Aggarwal R., Bose M. Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis. Immunology 2004, 112:471-480.
6. Ernst J.D. The immunological life cycle of tuberculosis. Nat Rev Immunol 2012, 12:581-591.
7. De Libero G., Mori L. The T-cell response to lipid antigens of Mycobacterium tuberculosis. Front Immunol 2014, 5:219.
8. Torrado E., Cooper A.M. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev 2010, 21:455-462.
9. Maglione P.J., Chan J. How B cells shape the immune response against Mycobacterium tuberculosis. Eur J Immunol 2009, 39:676-686.
10. Achkar J.M., Casadevall A. Antibody-mediated immunity against tuberculosis: implications for vaccine development. Cell Host Microbe 2013, 13:250-262.
11. O'Garra A.B., Britton W.J. Cytokines in tuberculosis 2008, Wiley-VCH, Weinheim.
12. Jo E.K., Yang C.S., Choi C.H., Harding C.V. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors. Cell Microbiol 2007, 9:1087-1098.
13. Philips J.A., Ernst J.D. Tuberculosis pathogenesis and immunity. Annu Rev Pathol 2012, 7:353-384.
14. Huynh K.K., Joshi S.A., Brown E.J. A delicate dance: host response to mycobacteria. Curr Opin Immunol 2011, 23:464-472.
15. Lowe D.M., Redford P.S., Wilkinson R.J., O'Garra A., Martineau A.R. Neutrophils in tuberculosis: friend or foe. Trends Immunol 2012, 33:14-25.
16. Cooper A.M., Mayer-Barber K.D., Sher A. Role of innate cytokines in mycobacterial infection. Mucosal Immunol 2011, 4:252-260.
17. Sato K., Tomioka H., Shimizu T., Gonda T., Ota F., Sano C. Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines. J Infect Dis 2002, 185:1139-1147.
18. Harriff M.J., Cansler M.E., Toren K.G., Canfield E.T., Kwak S., Gold M.C., et al. Human lung epithelial cells contain Mycobacterium tuberculosis in a late endosomal vacuole and are efficiently recognized by CD8(+) T cells. PLOS ONE 2014, 9:e97515.
19. Wickremasinghe M.I., Thomas L.H., Friedland J.S. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network. J Immunol 1999, 163:3936-3947.
20. O'Kane C.M., Boyle J.J., Horncastle D.E., Elkington P.T., Friedland J.S. Monocyte-dependent fibroblast CXCL8 secretion occurs in tuberculosis and limits survival of mycobacteria within macrophages. J Immunol 2007, 178:3767-3776.
21. Persson Y.A., Blomgran-Julinder R., Rahman S., Zheng L., Stendahl O. Mycobacterium tuberculosis-induced apoptotic neutrophils trigger a pro-inflammatory response in macrophages through release of heat shock protein 72, acting in synergy with the bacteria. Microbes Infect 2008, 10:233-240.
22. Krysko D.V., D'Herde K., Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 2006, 11:1709-1726.
23. Blomgran R., Ernst J.D. Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. J Immunol 2011, 186:7110-7119.
24. Mantovani A., Cassatella M.A., Costantini C., Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011, 11:519-531.
25. Blomgran R., Desvignes L., Briken V., Ernst J.D. Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4T cells. Cell Host Microbe 2012, 11:81-90.
26. Mourao-Sa D., Roy S., Blander J.M. Vita-PAMPs: signatures of microbial viability. Adv Exp Med Biol 2013, 785:1-8.
27. Bai W., Liu H., Ji Q., Zhou Y., Liang L., Zheng R., et al. TLR3 regulates mycobacterial RNA-induced IL-10 production through the PI3K/AKT signaling pathway. Cell Signal 2014, 26:942-950.
28. Sturgill-Koszycki S., Schlesinger P.H., Chakraborty P., Haddix P.L., Collins H.L., Fok A.K., et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994, 263:678-681.
29. Simeone R., Bottai D., Brosch R. ESX/type VII secretion systems and their role in host-pathogen interaction. Curr Opin Microbiol 2009, 12:4-10.
30. Aguilo J.I., Alonso H., Uranga S., Marinova D., Arbues A., de Martino A., et al. ESX-1-induced apoptosis is involved in cell-to-cell spread of Mycobacterium tuberculosis. Cell Microbiol 2013, 15:1994-2005.
31. Aguilo N., Marinova D., Martin C., Pardo J. ESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the question. Front Cell Infect Microbiol 2013, 3:88.
32. Houben D., Demangel C., van Ingen J., Perez J., Baldeon L., Abdallah A.M., et al. ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria. Cell Microbiol 2012, 14:1287-1298.
33. Carlsson F., Kim J., Dumitru C., Barck K.H., Carano R.A., Sun M., et al. Host-detrimental role of Esx-1-mediated inflammasome activation in mycobacterial infection. PLoS Pathog 2010, 6:e1000895.
34. Koo I.C., Wang C., Raghavan S., Morisaki J.H., Cox J.S., Brown E.J. ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection. Cell Microbiol 2008, 10:1866-1878.
35. Watson R.O., Manzanillo P.S., Cox J.S. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 2012, 150:803-815.
36. Vergne I., Chua J., Lee H.H., Lucas M., Belisle J., Deretic V. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2005, 102:4033-4038.
37. Briken V., Ahlbrand S.E., Shah S. Mycobacterium tuberculosis and the host cell inflammasome: a complex relationship. Front Cell Infect Microbiol 2013, 3:62.
38. Stanley S.A., Cox J.S. Host-pathogen interactions during Mycobacterium tuberculosis infections. Curr Top Microbiol Immunol 2013, 374:211-241.
39. Giacomini E., Remoli M.E., Scandurra M., Gafa V., Pardini M., Fattorini L., et al. Expression of proinflammatory and regulatory cytokines via NF-kappaB and MAPK-dependent and IFN regulatory factor-3-independent mechanisms in human primary monocytes infected by Mycobacterium tuberculosis. Clin Dev Immunol 2011, 2011:841346.
40. Remoli M.E., Giacomini E., Lutfalla G., Dondi E., Orefici G., Battistini A., et al. Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J Immunol 2002, 169:366-374.
41. Giacomini E., Remoli M.E., Gafa V., Pardini M., Fattorini L., Coccia E.M. IFN-beta improves BCG immunogenicity by acting on DC maturation. J Leukoc Biol 2009, 85:462-468.
42. Mayer-Barber K.D., Andrade B.B., Oland S.D., Amaral E.P., Barber D.L., Gonzales J., et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 2014, 511:99-103.
43. Dorhoi A., Kaufmann S.H. Tumor necrosis factor alpha in mycobacterial infection. Semin Immunol 2014, 26:203-209.
44. Moura-Alves P., Fae K., Houthuys E., Dorhoi A., Kreuchwig A., Furkert J., et al. AhR sensing of bacterial pigments regulates antibacterial defence. Nature 2014, 512:387-392.
45. Wallis R.S. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 2008, 8:601-611.
46. Zhang X., Majlessi L., Deriaud E., Leclerc C., Lo-Man R. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity 2009, 31:761-771.
47. Portevin D., Via L.E., Eum S., Young D. Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype. Cell Microbiol 2012, 14:1734-1744.
48. Giacomini E., Iona E., Ferroni L., Miettinen M., Fattorini L., Orefici G., et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001, 166:7033-7041.
49. Lande R., Giacomini E., Grassi T., Remoli M.E., Iona E., Miettinen M., et al. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J Immunol 2003, 170:1174-1182.
50. Ottenhoff T.H., Dass R.H., Yang N., Zhang M.M., Wong H.E., Sahiratmadja E., et al. Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS ONE 2012, 7:e45839.
51. Berry M.P., Graham C.M., McNab F.W., Xu Z., Bloch S.A., Oni T., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
52. Maertzdorf J., Weiner J.J3rd, Mollenkopf H.J., Bauer T., Prasse A., Muller-Quernheim J., et al. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A 2012, 109:7853-7858.
53. Verbon A., Juffermans N., Van Deventer S.J., Speelman P., Van Deutekom H., Van Der Poll T. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol 1999, 115:110-113.
54. Desvignes L., Wolf A.J., Ernst J.D. Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. J Immunol 2012, 188:6205-6215.
55. Joosten S.A., Fletcher H.A., Ottenhoff T.H. A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis. PLOS ONE 2013, 8:e73230.
56. Bogunovic D., Byun M., Durfee L.A., Abhyankar A., Sanal O., Mansouri D., et al. Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science 2012, 337:1684-1688.
57. Slight S.R., Khader S.A. Chemokines shape the immune responses to tuberculosis. Cytokine Growth Factor Rev 2013, 24:105-113.
58. Cooper A.M. T cells in mycobacterial infection and disease. Curr Opin Immunol 2009, 21:378-384.
59. Khader S.A., Partida-Sanchez S., Bell G., Jelley-Gibbs D.M., Swain S., Pearl J.E., et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med 2006, 203:1805-1815.
60. Tian T., Woodworth J., Skold M., Behar S.M. In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J Immunol 2005, 175:3268-3272.
61. Wolf A.J., Desvignes L., Linas B., Banaiee N., Tamura T., Takatsu K., et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med 2008, 205:105-115.
62. Srivastava S., Ernst J.D. Cell-to-cell transfer of M. tuberculosis antigens optimizes CD4T cell priming. Cell Host Microbe 2014, 15:741-752.
63. Samstein M., Schreiber H.A., Leiner I.M., Susac B., Glickman M.S., Pamer E.G. Essential yet limited role for CCR2+ inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming. eLife 2013, 2:e01086.
64. de Jonge M.I., Pehau-Arnaudet G., Fretz M.M., Romain F., Bottai D., Brodin P., et al. ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol 2007, 189:6028-6034.
65. Goriely S., Molle C., Nguyen M., Albarani V., Haddou N.O., Lin R., et al. Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 2006, 107:1078-1084.
66. Romagnoli A., Etna M.P., Giacomini E., Pardini M., Remoli M.E., Corazzari M., et al. ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells. Autophagy 2012, 8:1357-1370.
67. 2 vaccine immunogenicity. Altex 2014, May 20. 10.14573/altex.1311041.
68. Simeone R., Bobard A., Lippmann J., Bitter W., Majlessi L., Brosch R., et al. Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog 2012, 8:e1002507.
69. Khader S.A., Pearl J.E., Sakamoto K., Gilmartin L., Bell G.K., Jelley-Gibbs D.M., et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 2005, 175:788-795.
70. Cooper A.M., Solache A., Khader S.A. Interleukin-12 and tuberculosis: an old story revisited. Curr Opin Immunol 2007, 19:441-447.
71. Pearl J.E., Khader S.A., Solache A., Gilmartin L., Ghilardi N., deSauvage F., et al. IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J Immunol 2004, 173:7490-7496.
72. Holscher C., Holscher A., Ruckerl D., Yoshimoto T., Yoshida H., Mak T., et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 2005, 174:3534-3544.
73. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006, 7:937-945.
74. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007, 8:1363-1371.
75. Demangel C., Bertolino P., Britton W.J. Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur J Immunol 2002, 32:994-1002.
76. Beamer G.L., Flaherty D.K., Assogba B.D., Stromberg P., Gonzalez-Juarrero M., De Waal Malefyt R., et al. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J Immunol 2008, 181:5545-5550.
77. Turner J., Gonzalez-Juarrero M., Ellis D.L., Basaraba R.J., Kipnis A., Orme I.M., et al. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 2002, 169:6343-6351.
78. Awomoyi A.A., Marchant A., Howson J.M., McAdam K.P., Blackwell J.M., Newport M.J. Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis 2002, 186:1808-1814.
79. O'Leary S., O'Sullivan M.P., Keane J. IL-10 blocks phagosome maturation in Mycobacterium tuberculosis-infected human macrophages. Am J Respir Cell Mol Biol 2011, 45:172-180.
80. Remoli M.E., Giacomini E., Petruccioli E., Gafa V., Severa M., Gagliardi M.C., et al. Bystander inhibition of dendritic cell differentiation by Mycobacterium tuberculosis-induced IL-10. Immunol Cell Biol 2011, 89:437-446.
81. Reiley W.W., Calayag M.D., Wittmer S.T., Huntington J.L., Pearl J.E., Fountain J.J., et al. ESAT-6-specific CD4T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci U S A 2008, 105:10961-10966.
82. Silva Miranda M., Breiman A., Allain S., Deknuydt F., Altare F. The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria?. Clin Dev Immunol 2012, 2012:139127.
83. Al-Muhsen S., Casanova J.L. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol 2008, 122:1043-1051. quiz 1052-1043.
84. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993, 178:2249-2254.
85. Pieters J. Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe 2008, 3:399-407.
86. Derrick S.C., Yabe I.M., Yang A., Morris S.L. Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4T cells. Vaccine 2011, 29:2902-2909.
87. Caccamo N., Guggino G., Joosten S.A., Gelsomino G., Di Carlo P., Titone L., et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010, 40:2211-2220.
88. McAleer J.P., Kolls J.K. Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense. Immunol Rev 2014, 260:129-144.
89. Gopal R., Monin L., Slight S., Uche U., Blanchard E., Fallert Junecko B.A., et al. Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. PLoS Pathog 2014, 10:e1004099.
90. Torrado E., Robinson R.T., Cooper A.M. Cellular response to mycobacteria: balancing protection and pathology. Trends Immunol 2011, 32:66-72.
91. Khader S.A., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007, 8:369-377.
92. Wolk K., Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 2006, 17:367-380.
93. Ouyang W., Rutz S., Crellin N.K., Valdez P.A., Hymowitz S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 2011, 29:71-109.
94. Zenewicz L.A., Flavell R.A. Recent advances in IL-22 biology. Int Immunol 2011, 23:159-163.
95. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006, 203:2271-2279.
96. Behrends J., Renauld J.C., Ehlers S., Holscher C. IL-22 is mainly produced by IFNgamma-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection. PLoS ONE 2013, 8:e57379.
97. Winau F., Weber S., Sad S., de Diego J., Hoops S.L., Breiden B., et al. Apoptotic vesicles crossprime CD8T cells and protect against tuberculosis. Immunity 2006, 24:105-117.
98. Ottenhoff T.H., Kaufmann S.H. Vaccines against tuberculosis: where are we and where do we need to go?. PLoS Pathog 2012, 8:e1002607.
99. Marin N.D., Paris S.C., Velez V.M., Rojas C.A., Rojas M., Garcia L.F. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis (Edinb) 2010, 90:252-261.
100. Garg A., Barnes P.F., Roy S., Quiroga M.F., Wu S., Garcia V.E., et al. Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur J Immunol 2008, 38:459-469.
101. Shafiani S., Tucker-Heard G., Kariyone A., Takatsu K., Urdahl K.B. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 2010, 207:1409-1420.
102. Kursar M., Koch M., Mittrucker H.W., Nouailles G., Bonhagen K., Kamradt T., et al. Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 2007, 178:2661-2665.
103. Joosten S.A., Ottenhoff T.H. Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination. Hum Immunol 2008, 69:760-770.
104. Afzali B., Mitchell P., Lechler R.I., John S., Lombardi G. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol 2010, 159:120-130.
105. Kaufmann S.H. Tuberculosis vaccines: time to think about the next generation. Semin Immunol 2013, 25:172-181.
106. Keane J., Gershon S., Wise R.P., Mirabile-Levens E., Kasznica J., Schwieterman W.D., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001, 345:1098-1104.
107. Taylor P.C., Feldmann M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 2009, 5:578-582.
108. Casanova J.L., Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002, 20:581-620.
109. Abebe F. Is interferon-gamma the right marker for bacille Calmette-Guerin-induced immune protection? The missing link in our understanding of tuberculosis immunology. Clin Exp Immunol 2012, 169:213-219.